Dexcom's total assets for Q3 2024 were $6.35B, a decrease of -6.55% from the previous quarter. DXCM total liabilities were $4.37B for the fiscal quarter, a 0.23% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.